Allakos Inc

NASDAQ:ALLK   1:47:22 PM EDT
6.89
+0.16 (+2.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Allakos Inc Stock, NASDAQ:ALLK

825 Industrial Road, Suite 500, San Carlos, California 94070
United States of America
Phone: +1.650.597.5002
Number of Employees: 192

Description

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.